Current knowledge of hybrid nanoplatforms composed of exosomes and organic/inorganic nanoparticles for disease treatment and cell/tissue imaging - 21/08/24
Abstract |
Exosome-nanoparticle hybrid nanoplatforms, can be prepared by combining exosomes with different types of nanoparticles. The main purpose of combining exosomes with nanoparticles is to overcome the limitations of using each of them as drug delivery systems. Using nanoparticles for drug delivery has some limitations, such as high immunogenicity, poor cellular uptake, low biocompatibility, cytotoxicity, low stability, and rapid clearance by immune cells. However, using exosomes as drug delivery systems also has its own drawbacks, such as poor encapsulation efficiency, low production yield, and the inability to load large molecules. These limitations can be addressed by utilizing hybrid nanoplatforms. Additionally, the use of exosomes allows for targeted delivery within the hybrid system. Exosome-inorganic/organic hybrid nanoparticles may be used for both therapy and diagnosis in the future. This may lead to the development of personalized medicine using hybrid nanoparticles. However, there are a few challenges associated with this. Surface modifications, adding functional groups, surface charge adjustments, and preparing nanoparticles with the desired size are crucial to the possibility of preparing exosome-nanoparticle hybrids. Additional challenges for the successful implementation of hybrid platforms in medical treatments and diagnostics include scaling up the manufacturing process and ensuring consistent quality and reproducibility across various batches. This review focuses on various types of exosome-nanoparticle hybrid systems and also discusses the preparation and loading methods for these hybrid nanoplatforms. Furthermore, the potential applications of these hybrid nanocarriers in drug/gene delivery, disease treatment and diagnosis, and cell/tissue imaging are explained.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | Exosomes offer unique properties for drug delivery and imaging. |
• | Nanoparticles can be integrated with exosomes for hybrid nano platforms. |
• | Hybrid nano platforms combine exosome and nanoparticle advantages. |
• | Hybrid nano platforms overcome limitations of exosomes or nanoparticles separately. |
Abbreviations : EVs, MVBs, ILVs, PEG, NTA, RIC, EPR, DOX, UHMWPE, RE, REM, MPEG-PLGA, AS-LP, DCs, ECM, CLD, AVV, BBB, SgRNA, DTX, PDT, DAF, PDT, HUVECs, HSFs, GQDs
Keywords : Exosome, Hybrid nanoparticles, Treatment, Imaging, Drug delivery, Gene delivery
Plan
Vol 178
Article 117248- septembre 2024 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?